caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb .... Third, he contends defendants knowingly conspired with Medco and others to violate ...

caselaw.findlaw.com/us-1st-circuit/1858969.html

May 2, 2017 ... ASTRAZENECA PHARMACEUTICAL LP ASTRAZENECA LP. ... TAYMARI DELGADO ECHEVARRÍA, Plaintiff, Appellant, v. ... As in all other summary- judgment cases, we view the facts (and all reasonable inferences that can ...

www.law360.com/cases/59e6216bb9a1b52a7e000001

Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...

casetext.com/case/emory-v-astrazeneca-pharmaceuticals

In addition to his position at AstraZeneca, Mr. Emory owns his own cleaning ... a court must review all of the evidence and construe all inferences in the light most .... After reviewing the record evidence in the light most favorable to Mr. Emory, ...

www.ncbi.nlm.nih.gov/pubmed/29253412

... AlHabib KF(7), Kaur M(8), Kruger L(9), Teo K(10), Lanas F(11), Yusoff K(12), Oguz ... Bahonar A(16), Kutty R(17), Rosengren A(18), Mohan V(19), Avezum A( 20), ... Auger D, De Bluts AL, Proulx MC, Cayer M, Bonneville N, Lear S, Gasevic D, .... Care, pharmaceutical companies (with major contributions from AstraZeneca ...

globalinvestigationsreview.com/digital_assets/e1ec8b5a-8f5b-48fe-ab69-480c719c49f8/Atchley-et-al-v-AstraZeneca-et-al--Second-amended-complaint-(4-February-2019).pdf

Feb 4, 2019 ... LAWRENCE KRUGER, individually, and for the .... ASTRAZENECA PHARMACEUTICALS LP, GE ...... 2 Paul A. Volcker et al., Manipulation of the Oil- for-Food Programme by the Iraqi Regime (Oct. 27, 2005) ... 33-41, SEC v.

www.symlinhcp.com/clinical-efficacy/type-1-diabetes.html

Type 1 Diabetes: nausea (48% vs 17%), anorexia (17% vs 2%), inflicted injury ... AstraZeneca Pharmaceuticals LP. Whitehouse F, Kruger DF, Fineman M, et al.

www.medscape.org/viewarticle/900279

Aug 13, 2018 ... In this roundtable, clinicians who treat people with diabetes discuss the use of the ambulatory glucose profile.